CONSORTIUM AGREEMENT GL Capital Management GP Limited Jade Park Investments Limited Bank of China Group Investment Limited and ABG Management Limited Dated as of February 22, 2016Consortium Agreement • February 22nd, 2016 • Jade Park Investments LTD • Pharmaceutical preparations • Hong Kong
THIS CONSORTIUM AGREEMENT is made as of February 22, 2016, by and between GL Capital Management GP Limited, a company incorporated under the laws of Cayman Islands (“GL Capital”), Jade Park Investments Limited, a company incorporated under the laws of the Cayman Islands (“Jade Park”), Bank of China Group Investment Limited, a company incorporated under the laws of Hong Kong (“BOCGI”) and ABG Management Limited, a company incorporated under the laws of the Cayman Islands (“ABG”). Each of GL Capital, Jade Park, BOCGI and ABG is referred to herein as a “Consortium Member” and collectively, the “Consortium Members”. Unless otherwise set forth herein, capitalized terms have the meanings ascribed to such terms as set forth in Section 9.01.
Joint Filing AgreementJoint Filing Agreement • February 22nd, 2016 • Jade Park Investments LTD • Pharmaceutical preparations
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value US$0.001 per share, of SciClone Pharmaceuticals, Inc., a Delaware corporation, and further agree that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
